BFRIW · Insider Trading
Biofrontera Inc. Warrants
Every open-market purchase and sale reported by BFRIW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | John J Borer III | Director | A | +20,000 deriv. | — |
| 2026-03-06 | George Patrick Jones | Chief Commercial Officer | A | +100,000 deriv. | — |
| 2026-03-06 | Eugene Frederick Leffler | Chief Financial Officer | M | +87,500 | — |
| 2026-03-06 | Heikki Lanckriet | Director | A | +20,000 deriv. | — |
| 2026-03-06 | Hermann Luebbert | CEO & Chairman | M | +137,500 | — |
| 2026-03-06 | Kevin Daniel Weber | Director | A | +20,000 deriv. | — |
| 2026-03-06 | Beth J. Hoffman | Director | A | +20,000 deriv. | — |
| 2025-09-18 | Biofrontera AG | Director | Buy | +3,019 deriv. | — |
| 2025-09-16 | John J Borer III | Director | A | +20,000 deriv. | — |
| 2025-09-16 | Heikki Lanckriet | Director | A | +20,000 deriv. | — |
| 2025-09-16 | Kevin Daniel Weber | Director | A | +20,000 deriv. | — |
| 2025-09-16 | Hermann Luebbert | CEO & Chairman | M | +137,500 | — |
| 2025-09-16 | George Patrick Jones | Chief Commercial Officer | A | +100,000 deriv. | — |
| 2025-09-16 | Beth J. Hoffman | Director | A | +20,000 deriv. | — |
| 2025-09-16 | Eugene Frederick Leffler | Chief Financial Officer | M | +87,500 | — |
| 2024-07-16 | Hermann Luebbert | CEO & Chairman | A | +550,000 deriv. | — |
| 2024-07-16 | Heikki Lanckriet | Director | A | +20,000 deriv. | — |
| 2024-07-16 | John J Borer III | Director | A | +20,000 deriv. | — |
| 2024-07-16 | Beth J. Hoffman | Director | A | +20,000 deriv. | — |
| 2024-07-16 | Eugene Frederick Leffler | Chief Financial Officer | A | +350,000 deriv. | — |
| 2024-07-16 | Kevin Daniel Weber | Director | A | +20,000 deriv. | — |
| 2024-05-22 | Hermann Luebbert | CEO & Exec. Chairman | M | +4,771 | — |
| 2023-05-22 | Erica L. Monaco | Chief Executive Officer | M | +76,336 | — |
| 2023-05-22 | Hermann Luebbert | Executive Chairman | M | +95,420 | — |
| 2023-01-12 | Eugene Frederick Leffler | Chief Financial Officer | A | +100,000 deriv. | — |
| 2022-09-19 | Hermann Luebbert | Executive Chairman | M | +113,379 | — |
| 2022-09-19 | Erica L. Monaco | Chief Executive Officer | M | +56,689 | — |
| 2022-06-06 | Kevin Daniel Weber | Director | A | +22,000 deriv. | — |
| 2022-06-06 | Beth J. Hoffman | Director | A | +22,000 deriv. | — |
| 2022-06-06 | Loretta M. Wedge | Director | A | +22,000 deriv. | — |
| 2022-06-06 | John J Borer III | Director | A | +22,000 deriv. | — |
| 2022-05-26 | Beth J. Hoffman | Director | A | +22,000 deriv. | — |
| 2022-05-26 | Loretta M. Wedge | Director | A | +22,000 deriv. | — |
| 2022-05-26 | Hermann Luebbert | Executive Chairman | A | +381,680 deriv. | — |
| 2022-05-26 | John J Borer III | Director | A | +22,000 deriv. | — |
| 2022-05-26 | Erica F. Gates | Senior Director Finance | A | +19,084 deriv. | — |
| 2022-05-26 | Kevin Daniel Weber | Director | A | +22,000 deriv. | — |
| 2022-05-26 | Erica L. Monaco | Chief Executive Officer | A | +305,344 deriv. | — |
| 2022-01-19 | Erica L. Monaco | Chief Executive Officer | A | +56,689 deriv. | — |
| 2022-01-19 | Erica F. Gates | Controller | A | +20,408 deriv. | — |
| 2022-01-19 | Hermann Luebbert | Executive Chairman | A | +226,758 deriv. | — |
| 2021-12-13 | Erica F. Gates | Controller | A | +20,408 deriv. | — |
| 2021-12-13 | Erica L. Monaco | Chief Executive Officer | A | +113,378 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Hermann Luebbert | CEO & Chairman | 290,211 | $4.30K |
| Eugene Frederick Leffler | Chief Financial Officer | 175,000 | $2.59K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BFRIW quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.